MYHEMVIE
Live / Registered — Registered (as of 12 Jul 2022)
What this means for you
Registered since 12 Jul 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79309123
- Registration number
- 6784061
- Mark type
- Stylized text
- Filed
- 26 Feb 2021
- Published for opposition
- 26 Apr 2022
- Registered
- 12 Jul 2022
- Attorney of record
- Christopher K. Albert
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in gene therapy, namely, for treatment of sickle cell disease
Owner
- Bluebird Bio, Inc., DE, US
- Bluebird Bio, Inc., DE, US
- Genetix Biotherapeutics, Inc., US
- bluebird bio, Inc., DE, US
- Bluebird Bio (UK) Ltd., GB
Prosecution history
- 18 Dec 2025 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 14 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 18 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Sept 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 23 Dec 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 14 Nov 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 19 Oct 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 19 Oct 2022 — FINAL DISPOSITION PROCESSED
- 12 Oct 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 26 Aug 2022 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 12 Jul 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Jul 2022 — REGISTERED-PRINCIPAL REGISTER
- 09 May 2022 — NOTIFICATION PROCESSED BY IB